Abstract
AI-enhanced pathology evaluation systems hold significant potential to improve cancer diagnosis but frequently exhibit biases against underrepresented populations due to limited diversity in training data. Here, we present the Fairness-aware Artificial Intelligence Review for Pathology (FAIR-Path), a framework that leverages contrastive learning and weakly supervised machine learning to mitigate bias in AI-based pathology evaluation. In a pan-cancer AI fairness analysis spanning 20 cancer types, we identify significant performance disparities in 29.3% of diagnostic tasks across demographic groups defined by self-reported race, gender, and age. FAIR-Path effectively mitigates 88.5% of these disparities, with external validation showing a 91.1% reduction in performance gaps across 15 independent cohorts. We find that variations in somatic mutation prevalence among populations contribute to these performance disparities. FAIR-Path represents a promising step toward addressing fairness challenges in AI-powered pathology diagnoses and provides a robust framework for mitigating bias in medical AI applications.
| Original language | English |
|---|---|
| Article number | 102527 |
| Journal | Cell Reports Medicine |
| Volume | 6 |
| Issue number | 12 |
| DOIs | |
| Publication status | Published - 2025 Dec 16 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- General Medicine
- General Biochemistry,Genetics and Molecular Biology
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver